AUS
NZ
UK
CA
USA
IND
Healthcare
Small-Cap Surprise: This ASX Healthcare Stock Turning Heads
April 29, 2026 10:27 AM AEST| By SamBiome Australia’s expanding probiotic business, distribution growth, and operational changes highlight its evolving position within the healthcare sector and broader Australian share market.
Why Is (ASX:DXB) Dimerix Advancing Its Phase 3 Strategy?
April 28, 2026 08:07 PM AEST| By SamDimerix advances its Phase 3 kidney disease trial with improved design clarity, regulatory alignment, and steady progress, setting the stage for a crucial clinical outcome.
Why Is (ASX:AVR) Advancing Its Heart Valve Study in the US?
April 28, 2026 08:01 PM AEST| By Sam(ASX:AVR) gains US Medicare support for its global valve trial, boosting study expansion and strengthening progress in advanced heart disease treatment innovation.
ASX 200: Most Shorted Stocks and Shifting Sentiment in Week Eighteen
April 28, 2026 06:19 PM AEST| By Team Kalkine MediaShort interest trends across ASX stocks highlight shifting positioning in biotech, mining, and consumer sectors, with Telix leading activity amid notable corporate developments.
What’s Driving the Leadership Shift at (ASX:EVE)?
April 28, 2026 06:15 PM AEST| By SamEVE Health Group reshapes leadership to accelerate commercialisation, strengthen regulatory focus, and advance drug reformulation strategy within the evolving healthcare sector.
ASX 200 Today Watch: Is This Biotech Near Breakthrough?
April 28, 2026 04:44 PM AEST| By Team Kalkine MediaBiotech innovation continues to evolve as companies advance clinical and commercial strategies, highlighting the growing importance of regenerative medicine within Australia’s dynamic market landscape.
ASX 200 Healthcare Update: Pro Medicus vs Cochlear
April 28, 2026 04:10 PM AEST| By SamPro Medicus and Cochlear highlight activity within the ASX healthcare sector, reflecting medical technology development and integration into global healthcare systems.
What Is Driving Strong Clinical Momentum for Orthocell?
April 28, 2026 03:22 PM AEST| By SamOrthocell’s Remplir gains attention with strong clinical outcomes, expanding adoption, and supportive reimbursement, highlighting its growing role in nerve repair and regenerative healthcare innovation.
Top 3 Healthcare Shares Driving ASX 200 Today Sector Momentum
April 28, 2026 03:03 PM AEST| By SamASX healthcare stocks reflect sector resilience, driven by innovation, global operations, and consistent demand, with major companies maintaining strong presence across key indices.
Why Are ASX Healthcare Shares Drawing Fresh Attention?
April 28, 2026 02:41 PM AEST| By SamASX healthcare shares face pressure, yet select companies like Sigma Healthcare, Polynovo, and Pro Medicus continue to show resilience through innovation, operational strength, and expanding global presence.
ASX Healthcare Update: Island Pharma Expands Capital Base
April 28, 2026 01:50 PM AEST| By SamIsland Pharmaceuticals’ new share listing reflects ongoing capital management, supporting financial flexibility within the healthcare sector as companies continue to fund development and operational growth.
ASX All Ordinaries Biotech Update: US Deal Expansion
April 28, 2026 01:42 PM AEST| By SamClinuvel Pharmaceuticals advances US agreement, highlighting global collaboration and regulatory engagement within the biotechnology and healthcare sector.
ASX Small Cap Shock: Why Dimerix Tumbled Despite Strong Trial Signals
April 28, 2026 11:24 AM AEST| By SamDimerix’s sharp decline reflects a timeline shift and loss of near-term catalysts, while its clinical progress remains unchanged, highlighting biotech sector sensitivity to expectations.
ASX 200 CSL Limited (ASX:CSL) Healthcare Stock Under Pressure After Update?
April 28, 2026 10:50 AM AEST| By SamCSL Limited draws attention as share movement occurs despite recent updates, reflecting broader healthcare sector dynamics and evolving market sentiment across ASX benchmarks.
ASX 200 Volatility: Is Market Chaos Hiding Opportunity?
April 28, 2026 10:07 AM AEST| By SamASX 200 volatility highlights shifting sentiment across sectors, with blue-chip stocks under pressure as global factors drive short-term movements despite stable long-term fundamentals.
Healthcare AI Firm Artrya Gains Momentum In ASX 200 Trading Session
April 27, 2026 02:38 PM AEST| By Team Kalkine MediaArtrya Limited’s intraday movement reflects ongoing activity in the healthcare AI sector on the Australian exchange, supported by strong liquidity and continued focus on diagnostic technology development.
Is ASX 200 Healthcare Sector Led by Pro Medicus (ASX:PME)?
April 27, 2026 02:35 PM AEST| By SamPro Medicus highlights strong healthcare sector activity on the ASX, with medical technology and digital solutions driving market attention.
Why Mach7 Technologies Could Rebound Strongly Soon
April 27, 2026 02:29 PM AEST| By Team Kalkine MediaHealthcare technology continues evolving with strong demand for digital imaging solutions, highlighting growth potential, innovation focus, and improving financial stability within the broader Australian market landscape.
What’s Driving Momentum in (ASX:TTX) This Year?
April 27, 2026 02:27 PM AEST| By SamTetratherix is gaining attention in the healthcare space with steady innovation, clinical progress, and expanding partnerships, positioning the company for continued developments in regenerative and precision medicine.
ASX Small-Cap Healthcare Stock: Is Mach7 Gearing Up for a Comeback?
April 27, 2026 01:51 PM AEST| By SamMach7 Technologies is navigating a transition phase with improved cost discipline and a stronger recurring revenue focus, while execution and pipeline conversion remain key factors shaping market sentiment.
Advertise your brand on Kalkine Media